Molecular therapy for hepatic injury and fibrosis: where are we?
about
Evolving Insights on Metabolism, Autophagy, and Epigenetics in Liver MyofibroblastsReversibility and heritability of liver fibrosis: Implications for research and therapyPDGFRα in liver pathophysiology: emerging roles in development, regeneration, fibrosis, and cancerAnandamide induces cell death through lipid rafts in hepatic stellate cells.Involvement of DNA damage response pathways in hepatocellular carcinoma.Time course of gene expression profiling in the liver of experimental mice infected with Echinococcus multilocularisCell fusion reprogramming leads to a specific hepatic expression pattern during mouse bone marrow derived hepatocyte formation in vivo.Small RNA- and DNA-based gene therapy for the treatment of liver cirrhosis, where we are?Mutant MMP-9 and HGF gene transfer enhance resolution of CCl4-induced liver fibrosis in rats: role of ASH1 and EZH2 methyltransferases repressionPegylated interferon-alpha plus taurine in treatment of rat liver fibrosisIL-17A G197A gene polymorphism contributes to susceptibility for liver cirrhosis development from patients with chronic hepatitis B infection in Chinese populationEvaluation of the Chinese Medicinal Herb, Graptopetalum paraguayense, as a Therapeutic Treatment for Liver Damage in Rat Models.Moderate (2%, v/v) Ethanol Feeding Alters Hepatic Wound Healing after Acute Carbon Tetrachloride Exposure in MiceTargeting the PDGF-B/PDGFR-β Interface with Destruxin A5 to Selectively Block PDGF-BB/PDGFR-ββ Signaling and Attenuate Liver FibrosisEffects of Fufang Biejia Ruangan pills on hepatic fibrosis in vivo and in vitro.Effect of Oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl4-induced hepatic fibrosis.Corn peptides protect against thioacetamide-induced hepatic fibrosis in ratsSoluble TNF-α receptor I encoded on plasmid vector and its application in experimental gene therapy of radiation-induced lung fibrosis.Ecto-5'-nucleotidase/CD73 knockdown increases cell migration and mRNA level of collagen I in a hepatic stellate cell line.Activity and expression of ecto-nucleotide pyrophosphate/phosphodiesterases in a hepatic stellate cell line.Importance of detoxifying enzymes in differentiating fibrotic development between SHRSP5/Dmcr and SHRSP ratsRole of free radicals in liver diseases.Loss of clock gene mPer2 promotes liver fibrosis induced by carbon tetrachloride.Allopurinol reverses liver damage induced by chronic carbon tetrachloride treatment by decreasing oxidative stress, TGF-β production and NF-κB nuclear translocation.The protective effect of vitamin D against carbon tetrachloride damage to the rat liver.The Effects of Hyperbaric Oxygen Treatment on Total Antioxidant Capacity and Prolidase Activity after Bile Duct Ligation in Rats.
P2860
Q26745566-586D908E-C012-465F-B0DE-3752DE32DAB4Q27026622-0FB4028F-C9CD-4BF5-B219-D67F5340B20AQ28085644-DDA63B67-3CB0-49AB-AA2C-9AA2A50036CFQ33522772-112C4421-897C-4C31-AF47-C02B880B07CDQ33616812-59001D88-C0C2-414D-BCA7-9769FE7C6E40Q33809462-63230F08-8F56-4947-8B9B-964FE9351FA6Q34212061-FBE9D02B-2213-4B0B-BB4C-67E18CE65E9DQ34405044-4637D63D-3A70-4F41-8905-40619A8C10B9Q34473076-316039D9-4126-4D1C-BCBE-F78CE4DBBD12Q35621270-DC5900CE-7F96-499E-A99C-3F4A44CC7870Q35958731-66CBC295-8BCC-4D9D-A06E-0DCF9D309DF6Q36090999-D62CF443-DFAA-4328-AF75-76BC9D31BE0BQ36731858-D6746D35-6ED9-44A1-A40E-AB2C23F255F6Q37009087-944C12BF-1FD0-40FC-AECF-6F73D33EEB4FQ37118860-8AF02C98-B0B1-4F0A-8D8A-17699B810DEDQ37240434-5F2429DB-46A5-4896-8415-2BDB25A936C6Q37250500-F13EEA54-6513-45CB-931F-7D80F31FC4D1Q39531846-DA2FB35E-0DC3-4EAA-A084-1A146F359523Q39572713-424F2702-11D4-433C-92B2-9A56CF6D5EA3Q39887352-FB86D569-073F-4B48-A542-81D5E221BE29Q41885280-1A437209-DB7F-4CEB-9B0C-C75C5ED87777Q41983643-C785F3A7-3B6E-4652-B4F2-D2A8A61B412EQ42873673-5342E902-6AEA-4200-996F-0A41AEA4C681Q45807860-BDDF65BA-7241-48D6-BCB3-2741FB3C7420Q47676361-113B3F29-3D50-4FC2-8FC0-4909C9C32573Q51283297-4CD7CDA6-19CA-41DE-AC04-4989AE72D52B
P2860
Molecular therapy for hepatic injury and fibrosis: where are we?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Molecular therapy for hepatic injury and fibrosis: where are we?
@en
Molecular therapy for hepatic injury and fibrosis: where are we?
@nl
type
label
Molecular therapy for hepatic injury and fibrosis: where are we?
@en
Molecular therapy for hepatic injury and fibrosis: where are we?
@nl
prefLabel
Molecular therapy for hepatic injury and fibrosis: where are we?
@en
Molecular therapy for hepatic injury and fibrosis: where are we?
@nl
P2093
P2860
P356
P1476
Molecular therapy for hepatic injury and fibrosis: where are we?
@en
P2093
Colette C Prosser
P2860
P304
P356
10.3748/WJG.V12.I4.509
P407
P577
2006-01-01T00:00:00Z